On May 28, the IPO of Auchangyuan Intelligent Equipment Co., Ltd. Shenzhen Stock Exchange GEM has been accepted.
Cathay Haitong Securities is its sponsor and plans to raise 1.25105 billion yuan.
The prospectus shows that Auchangyuan takes separation and purification technology as the core and process development as the leader, and is mainly engaged in the research and development, production and sales of separation and purification equipment and industrial automation control systems.
During the reporting period, the company’s main business income mainly consisted of separation and purification equipment, industrial automation control systems and other biological manufacturing equipment.
In terms of process development, the company develops production process routes based on the specific needs of downstream industries and different application scenarios to help downstream industries achieve the goals of improving quality, saving energy, reducing consumption, and increasing efficiency.
For example, the company can accurately design the most suitable production process for different biomanufacturing products, significantly improving product quality and production efficiency.
In terms of equipment manufacturing, the company has independently developed mass production capabilities for multiple categories of separation and purification equipment such as ion exchange, chromatographic separation, molecular distillation, evaporation, crystallization, and drying.
This means that the company can provide a variety of equipment options according to the different needs of customers to meet various complex production requirements.
At the same time, the company’s independently developed industrial automation control system integrates the overall production line process and multi-category separation and purification technology, and creates a full-line intelligent manufacturing solution based on automated instrumentation and industrial software to achieve stable large-scale production and effective control of the process.
Through this intelligent control system, the company can monitor various parameters in the production process in real time, adjust production strategies in a timely manner, and ensure the stability of product quality and maximize production efficiency.
Separation and purification, as the core technology for mixture separation, target substance purification and impurity removal, is a key link in large-scale production in biomanufacturing and other fields.
Separation and purification equipment and industrial automation control systems serve as core carriers to achieve large-scale preparation of high-purity target products and play an important role in the industrialization of this field.
After years of development, Auchangyuan has mature process development and equipment manufacturing capabilities in biomanufacturing subdivisions such as functional sugars, starch sugars, bio-based platform compounds, and amino acids. It is able to deliver complete production solutions to customers, and continues to develop in other fields such as sucrose and hydrometallurgy.
Take the emerging synthetic biological product psicose as an example. According to data from Zhuochuang Information, from 2023 to 2025, the company’s market share in separation and purification related businesses in the field of psicose reached 50.55%, ranking first in the country.
This fully demonstrates the company’s strong competitiveness and technical strength in this field.
In terms of finance, in 2023, 2024, and 2025, the company will achieve operating income of approximately 360 million yuan, 399 million yuan, and 580 million yuan respectively; during the same period, net profits will be approximately 107 million yuan, 118 million yuan, and 151 million yuan respectively.
Good financial performance also provides a solid foundation for the company’s further development.
